Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat.
The polycystic kidney (PCK) rat is an animal model of Caroli's disease as well as autosomal recessive polycystic kidney disease (ARPKD). The signaling pathways involving the mammalian target of rapamycin (mTOR) are aberrantly activated in ARPKD. This study investigated the effects of inhibitors for the cell signaling pathways including mTOR on cholangiocyte proliferation of the PCK rat. Cultured PCK cholangiocytes were treated with rapamycin and everolimus [inhibitors of mTOR complex 1 (mTOC1)], LY294002 [an inhibitor of phosphatidylinositol 3-kinase (PI3K)] and NVP-BEZ235 (an inhibitor of PI3K and mTORC1/2), and the cell proliferative activity was determined in relation to autophagy and apoptosis. The expression of phosphorylated (p)-mTOR, p-Akt, and PI3K was increased in PCK cholangiocytes compared to normal cholangiocytes. All inhibitors significantly inhibited the cell proliferative activity of PCK cholangiocytes, where NVP-BEZ235 had the most prominent effect. NVP-BEZ235, but not rapamycin and everolimus, further inhibited biliary cyst formation in the three-dimensional cell culture system. Rapamycin and everolimus induced apoptosis in PCK cholangiocytes, whereas NVP-BEZ235 inhibited cholangiocyte apoptosis. Notably, the autophagic response was significantly induced following the treatment with NVP-BEZ235, but not rapamycin and everolimus. Inhibition of autophagy using siRNA against protein-light chain3 and 3-methyladenine significantly increased the cell proliferative activity of PCK cholangiocytes treated with NVP-BEZ235. In vivo, treatment of the PCK rat with NVP-BEZ235 attenuated cystic dilatation of the intrahepatic bile ducts, whereas renal cyst development was unaffected. These results suggest that the aberrant activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat, and inhibition of the pathway can reduce cholangiocyte proliferation via the mechanism involving apoptosis and/or autophagy.
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan ; Department of Pathology, Yanbian University College of Medicine, Yanji-city, China.
Xiang Shan
XS
Ren
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Yasunori
Y
Sato
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Kenichi
K
Harada
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Motoko
M
Sasaki
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Shinichi
S
Furubo
Department of Pathology, Yanbian University College of Medicine, Yanji-city, China.
Jing Yu
JY
Song
Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan ; Department of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Yasuni
Y
Nakanuma
D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001343:Autophagy / Q000235:genetics; D049109:Cell Proliferation; D002478:Cells, Cultured; D058539:Phosphatidylinositol 3-Kinase / Q000235:genetics*; D007690:Polycystic Kidney Diseases / Q000235:genetics*; D051381:Rats; D015398:Signal Transduction / Q000235:genetics*; D058570:TOR Serine-Threonine Kinases / Q000235:genetics*
C546845:mTOR protein, rat; D058539:Phosphatidylinositol 3-Kinase; D058570:TOR Serine-Threonine Kinases